Bovigam mastitis is an intramammary preparation produced under strict sterile conditions having the following advantages:
. Synergistic 1.Potencia
. Trimethoprim (TMP) and sulfadiazine (SDZ)
2.Amplio bactericidal spectrum.
Very effective against germs that cause the vast majority of mastitis in lactating (especially Staphylococcus spp and Streptococcus spp ).
More than 40 hours with effective concentrations in breast tissue.
Packaged in syringes ready for use.
The combination of trimethoprim (TMP) and sulfadiazine (SDZ) is derived from activity inhibition power biosynthetic process used by microorganisms in nucleic acid synthesis.
Sulfadiazine inhibits incorporation of parabenzoic acid dihydrofolic acid and trimethoprim inhibits the enzyme dihidrofolate which becomes tetrahydrofolic acid.
the double lock exercised by the combination of TMP and SDZ, has a bactericidal effect contrary to bacteriostatic effect presenting the TMP and SDZ separately . Thus, trimethoprim potentiates greatly with the antimicrobial activity of sulfonamides, the combination is an excellent example of synergy between two antibacterial compounds.
This combination is broad spectrum and is effective against common pathogenic Gram - positive and Gram - negative mastitis.
To use exclusive Veterinarian.
Each syringe 8 g contains:
Trimethoprim ................... 40 mg
Sulfadiazine ................... 200 mg
Box with 12 syringes 8 g.
Apply the contents of a syringe into each mammary quarters affected, after each milking, for 3 consecutive milkings.
Treatment of mastitis in cattle.
Mastitis is a problem of great economic importance in cattle milking.
This is defined as an inflammation of the mammary gland, commonly a result of a bacterial infection.
A variety of bacterial species are listed as primary pathogens:
Corynebacterium (Actinomyces) pyogenes.
Predisposing factors for infection in the gland are unhygienic handling of the milking room injuries and environmental pollution. The disease can occur in a variety of forms from an acute clinical condition to chronic subclinical.
Animals should be treated when detected early signs of mastitis during lactation period.
After milking thoroughly before applying the product, the udder should be washed with an antiseptic solution. After application, massaging the udder to facilitate proper distribution of the suspension.
Milk for human consumption should not be used during treatment can only be used after 36 hours of the last treatment. The animals should not be slaughtered for consumption during the treatment, only 7 days later.
*Make sure to consult your Veterinarian before buying any medication.